How GMP Addresses Contamination and Cross-Contamination Risks in Biopharma
How GMP Addresses Contamination and Cross-Contamination Risks in Biopharma Strategies for Contamination Control in Biopharmaceutical Manufacturing Under GMP Introduction: The Threat of Contamination in Biopharma Contamination and cross-contamination are critical risks in biopharmaceutical manufacturing, potentially compromising product safety, efficacy, and regulatory compliance. Given the complexity of biopharmaceutical products, including vaccines, monoclonal antibodies, and cell therapies,…
Read More “How GMP Addresses Contamination and Cross-Contamination Risks in Biopharma” »